What is the appropriate workup for a 13‑week pregnant woman presenting with vaginal bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Workup for 13-Week Pregnant Woman with Bloody Discharge

Immediately obtain a transabdominal ultrasound, followed by transvaginal ultrasound if transabdominal imaging is inconclusive, and avoid digital pelvic examination until placental location is confirmed. 1

Critical First Steps

Avoid Digital Pelvic Examination

Do not perform a digital pelvic examination until placenta previa, low-lying placenta, and vasa previa have been excluded by ultrasound. 1 This is a critical safety measure at 13 weeks gestation, as digital examination could precipitate catastrophic hemorrhage if placental abnormalities are present.

Initial Clinical Assessment

Obtain vital signs immediately to assess hemodynamic stability. 2 Document:

  • Amount and character of bleeding (spotting vs. heavy flow)
  • Presence of pain (painless bleeding suggests different etiologies than painful bleeding)
  • Associated symptoms (cramping, passage of tissue, dizziness)
  • Prior cesarean delivery or uterine surgery (increases risk of uterine rupture and placental abnormalities)

Laboratory Workup

Order the following labs:

  • Rh factor determination - essential for Rh-negative patients 3, 4
  • Hemoglobin/hematocrit - assess blood loss 4
  • Quantitative hCG - though less useful once intrauterine pregnancy is confirmed on ultrasound 4
  • Blood type and screen - in case transfusion becomes necessary

Imaging Algorithm

Primary Imaging: Transabdominal Ultrasound

Start with transabdominal ultrasound as the initial screening tool. 1 This should evaluate:

  • Fetal viability (cardiac activity at 13 weeks should be clearly visible)
  • Placental location (exclude placenta previa - affects 1 in 200 pregnancies) 1
  • Placental appearance (look for abruption, though ultrasound detects only ~50% of cases) 1
  • Cervical length and appearance (from external to internal os) 1
  • Subchorionic hematoma (common benign finding)

Secondary Imaging: Transvaginal Ultrasound

Proceed to transvaginal ultrasound if transabdominal imaging is inconclusive or inadequate. 1 Transvaginal ultrasound is both accurate and safe, even with placenta previa. 1 This provides superior visualization of:

  • Cervical pathology (polyps, cervicitis, cervical insufficiency) 1
  • Placental edge location relative to internal os
  • Measurement of distance from placental edge to internal os 1

Add Doppler Velocimetry

Use color and spectral Doppler if vasa previa is suspected (vessels overlying the internal cervical os). 1 This distinguishes fetal from maternal vessels and is essential for diagnosing vasa previa, which affects 1 in 2,500-5,000 deliveries but carries high fetal mortality risk if undiagnosed. 1

Differential Diagnosis at 13 Weeks

At 13 weeks gestation, the patient is in early second trimester. Key etiologies include:

Life-threatening causes:

  • Placental abruption (1% of pregnancies; central abruption has worse outcomes) 1
  • Placenta previa (most common serious diagnosis)
  • Vasa previa (rare but catastrophic if undiagnosed)
  • Threatened miscarriage (still possible at 13 weeks)
  • Uterine rupture (rare, mainly with prior cesarean/uterine surgery) 1

Benign causes:

  • Cervical ectropion (bleeding from hypervascular cervix)
  • Cervical polyp
  • Cervicitis
  • Subchorionic hematoma
  • Vaginal laceration

Approximately 50% of cases have no identifiable cause despite thorough workup. 1

Special Considerations

Rh-Negative Patients

Administer 50 μg anti-D immunoglobulin to all Rh-negative patients with first or early second trimester bleeding. 3 While evidence for threatened abortion with viable fetus before 12 weeks is limited, at 13 weeks with bleeding, the risk of fetomaternal hemorrhage warrants prophylaxis to prevent alloimmunization.

If Ultrasound Shows Viable Intrauterine Pregnancy

  • Speculum examination is safe to visualize cervix and identify cervical sources of bleeding 1
  • Document cervical dilation, effacement, and visible bleeding source
  • Avoid digital examination unless placental location is confirmed away from cervix

If Ultrasound is Inconclusive

Consider transperineal (translabial) ultrasound if transvaginal is declined or transrectal ultrasound as alternatives. 1 These provide adequate cervical visualization when transvaginal approach is not feasible.

Common Pitfalls

Do not rely on amount of bleeding alone - small amounts can herald serious pathology, while heavy bleeding may be from benign cervical sources. 5

Do not skip ultrasound - clinical examination alone cannot exclude placental abnormalities that require modified management. 1

Do not perform digital examination first - this single error could cause massive hemorrhage if placenta previa is present. 1

Do not use CT or MRI - these have no role in routine first/early second trimester bleeding workup due to radiation exposure (CT) and lack of added diagnostic value. 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.